News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 244 results

Biogen blocking bid rejected; signs $2.4bn deal

US28-02-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit has rejected Biogen’s bid to block a generic version of its multiple sclerosis drug, pending an appeal against a lower court’s ruling.

University of California gains ground after EPO backs CRISPR patent

EU11-02-2020Sarah Morgan

In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.

Broad Institute presses for CRISPR settlement after EPO revocation

EU23-01-2020Rory O'Neill

A competitor of the Broad Institute has said that a European Patent Office ruling last week has weakened the CRISPR/Cas9 patent owner’s negotiating hand in any future settlement between the parties.

Illumina escapes genetics trade secrets claims

US17-01-2020Rory O'Neill

A US judge has thrown out a lawsuit accusing US biotechnology companies Illumina and Affymetrix of a “complex, multi-decade concerted effort” to conceal the theft of trade secrets in the 1990s.

Breaking: EPO revokes Broad’s CRISPR patent

16-01-2020Rory O'Neill

In a dramatic reversal, a European Patent Office’s board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent.

Breaking: EPO board to refer key issues in Broad appeal to higher panel

EU15-01-2020Rory O'Neill

The European Patent Office intends to refer questions in the Broad Institute’s ongoing CRISPR patent case to the enlarged board of appeal, meaning the case is set to drag out further.

EPO appeals board weighs-up Broad’s CRISPR claims

EU14-01-2020Rory O'Neill

The first day of a landmark hearing on CRISPR ownership dealt nearly exclusively with untangling linguistic arguments, lawyers following the proceedings told LSIPR.

Illumina and Pacific Biosciences terminate $1.2bn deal

US03-01-2020Sarah Morgan

Gene-sequencing companies Illumina and Pacific Biosciences have “mutually agreed” to terminate their $1.2 million merger agreement, under which Illumina would have acquired PacBio.

USPTO grants University of California 20th CRISPR patent

US02-01-2020Sarah Morgan

The US Patent and Trademark Office has granted the University of California its 20th US patent on CRISPR-Cas9 gene-editing technologies.

Fed Circuit says warning labels could be protectable by copyright

19-12-2019Rory O'Neill

Syngenta will be allowed to raise claims that Willowood infringed its copyright by copying warning labels on pesticides, the US Court of Appeals for the Federal Circuit ruled yesterday, December 18.

Showing 1 to 10 of 244 results

LSIPR